Cerebrovascular reserve capacity in patients with occlusive cerebrovascular disease: Assessment with dynamic susceptibility contrast- enhanced MR imaging and the acetazolamide stimulation test

Radiology

Volumn 201, Issue 2, 1996, Pages 405-412

  Gückel, Friedemann J ^a   Brix, Gunnar ^b   Schmiedek, Peter ^a   Piepgras, Axel ^a   Becker, Georg ^a   Köpke, Julian ^a   Gross, Holger ^a   Georgi, Max ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Brain, blood flow; Brain, diseases; Brain, perfusion; Magnetic resonance (MR), vascular studies

Indexed keywords

ACETAZOLAMIDE; GADOLINIUM PENTETATE MEGLUMINE;

ADULT; AGED; ARTICLE; BLOOD VOLUME; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTRAST ENHANCEMENT; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; MIDDLE CEREBRAL ARTERY; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL;

EID: 0029993875     PISSN: 00338419     EISSN: None     Source Type: Journal    
DOI: 10.1148/radiology.201.2.8888232     Document Type: Article

References (52)

1. Redzai K, Kirchner PT, Armstrong C, Erhardt JC. Validation studies for brain blood flow assessment by radioxenon tomography. J Nucl Med 1988; 29:348-355.
2. Sperling B, Lassen NA. Hyperfixation of HMPAO in subacute ischemic stroke leading to spuriously high estimates of cerebral blood flow by SPECT. Stroke 1993; 24:193-194.
3. Ryding E. Estimation of error limits for cerebral blood flow values obtained from xenon-133 clearance curves. Stroke 1989; 20:205-210.
4. Axel L. Cerebral blood flow determination by rapid-sequence computed tomography. Radiology 1980; 137:679-686.
5. Stewart GN. Researches on the circulation time in organs and on the influences which affect it. J Physiol 1894; 15:1-89.
6. Meier P, Zierler KL. On the theory of the indicator-dilution method for measurement of blood flow and volume. J Appl Physiol 1954; 6:731-744.
7. Zierler KL. Theoretical basis of indicator-dilution methods for measuring flow and volume. Cire Res 1962; 10:393-407.
8. Norman D, Axel L, Berninger WH, et al. Dynamic computed tomography of the brain: techniques, data analysis, and applications. AJR 1981; 136:759-770.
9. Rosen BR, Belliveau JW, Chien D. Perfusion imaging by nuclear magnetic resonance. Magn Reson Q 1989; 5:263-281.
10. Rosen BR, Belliveau JW, Vevea JM, Brady TJ. Perfusion imaging with NMR contrast agents. Magn Reson Med 1990; 14:249-265.
11. Rosen BR, Belliveau JW, Buchbinder BR, et al. Contrast agents and cerebral hemodynamics. Magn Reson Med 1991; 19:285-292.
12. Belliveau JW, Rosen BR, Kantor HL, et al. Functional cerebral imaging by susceptibility-contrast NMR. Magn Reson Med 1990; 14:538-346.
13. Edelman RR, Mattle HP, Atkinson DJ, et al. Cerebral blood flow: Assessment with dynamic contrast-enhanced T2*-weighted MR imaging at 1.5 T. Radiology 1990; 176:211-220.
14. Gückel F, Wentz K, Brix G, et al. MR-tomographische untersuchungen zur cerebralen durchblutung: methodische grundlagen und erste klinische erfahrungen mit T2* gewichteten gradientenechosequenzen und KM-gabe im bolus. ROFO 1992; 156:212-217.
15. Gückel F, Brix G, Deimling M, et al. Assessment of cerebral blood flow with dynamic contrast-enhanced T2*-weighted gradient echo images (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1992. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1992; 1133.
16. Gückel F, Brix G, Rempp K, Deimling M, Röther J, Georgi M. Assessment of cerebral blood volume with dynamic susceptibility contrast enhanced gradient echo imaging. J Comput Assist Tomogr 1994; 18: 344-351.
17. Boxerman JL, Weisskopf RM, Aronen H, Rosen BR. Signal-to-noise and tissue blood volume maps from dynamic NMR studies (abstr). In: Book of abstracts: Society of Magnetic Resonance in Medicine 1992. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1992; 1130.
18. Perman WH, Gado MH, Larson KB, Perlmutter JS. Simultaneous MR acquisition of arterial and brain signal-time curves Magn Reson Med 1992; 28:74-83.
19. Perman WH, Gado M, Larson KB, Perlmutter JS. The in vivo relationship between Gd-DTPA concentration and ΔR2 for brain parenchyma and arterial blood (abstr). In: Book of Abstracts: Society of Magnetic Resonance in Medicine 1993. Berkeley, Calif: Society of Magnetic Resonance in Medicine, 1993; 388.
20. Weisskoff RM, Chesler D, Boxerman L, Rosen BR. Pitfalls in MR measurement of tissue blood flow with intravascular tracers: which mean transit time? Magn Reson Med 1993; 29:553-559.
21. Gückel F, Brix G, Rempp K, Röther J, Georgi M. Assessment of cerebral hemodynamics in patients with vascular disorders and brain tumors. Adv MRI Contrast 1994; 2:94-100.
22. Moseley ME, Vexler Z, Asgari HS, et al. Comparison of Gd- and Dy-chelates for T2* contrast-enhanced imaging. Magn Reson Med 1991; 22:259-264.
23. Fisel CR, Ackerman JL, Buxton RB, et al. MR contrast due to microscopically heterogeneous magnetic susceptibility: numerical simulations and applications to cerebral physiology. Magn Reson Med 1991; 17:336-347.
24. Rempp K, Brix G, Gückel F, Becker C, Wenz F, Lorenz WJ. Quantification of regional cerebral blood flow and volume with dynamic susceptibility contrast-enhanced MR imaging. Radiology 1994; 193: 637-641.
25. Gückel F, Rempp K, Becker G, Köpke J, Loose R, Brix G. Kernspintomographie als funktionsdiagnostische methode: neue ansätze zur nichtinvasiven quantifizierung von zerebralem blutvolumen und blutfluss. Radiologe 1994; 34:619-626.
26. Gückel F, Brix G, Schmiedek P, et al. Nicht-invasive quantifizierung des zerebralen blutvolumens und blutflusses mit der dynamischen MR-tomographie: untersuchungen an probanden und patienten mit cerebrovasculärer insuffizienz. Radiologe 1995; 35:791-800.
27. Kreisig T, Schmiedek P, Leinsinger G, Einhäupl K, Moser E. 133-Xe-DSpect: normalwerte von zerebraler ruhedurchblutung und reservekapazität. Nucl Med 1987; 26:192-197.
28. Piepgras A, Schmiedek P, Leinsinger G, Haberl R, Kirsch CM, Einhäupl K. A simple test to assess cerebrovascular reserve capacity using transcranial Doppler sonography and acetazolamide Stroke 1990; 21:1306-1311.
29. Richter W, Hierholzer J, Rosenkranz K, et al. Die Wirkung von acetazolamid auf die hirndurchblutung bei patienten mit a. carotis Stenosen vor und nach thrombendarteriektomie-untersuchungen mit HMPAO-SPECT. J Pharmacol Ther 1992; 3:112-116.
30. Steiger HJ, Aaslid R, Stooss R. Dynamic computed tomographic imaging of regional cerebral blood flow and blood volume: a clinical pilot study. Stroke 1993; 24: 591-597.
31. Burt RW, Witt RM, Cikrit DF, Reddy RV. Carotid artery disease: evaluation with acetazolamide-enhanced Tc-99m HMPAO SPECT. Radiology 1992; 182:461-466.
32. Ehrenreich DL, Bruns RA, Alman RW, Fazekas JF. Influence of acetazolamide on cerebral blood flow. Arch Neurol 1961; 5:227-232.
33. Laux BE, Raichle ME. The effect of acetazolamide on cerebral blood flow and oxygen utilization in the rhesus monkey. J Clin Invest 1978; 62:585-592.
34. Severinghaus JW, Cotev S. Carbonic acidosis and cerebral vasodilatation after acetazolamide. Scand J Clin Lab Invest 1986; 1(suppl):102-114.
35. Bickler PE, Litt L, Banville DL, Severinghaus JW. Effects of acetazolamide on cerebral acid-base balance. J Appl Physiol 1988; 65:422-427.
36. Yamashita T, Hayashi M, Kashiwagi S, et al. Cerebrovascular reserve capacity in ischemia due to occlusion of a major arterial trunk: studies by Xe-CT and the acetazolamide test. J Comput Assist Tomogr 1992; 16:750-755.
37. Sabatini U, Celsis P, Viallard G, Rascol A, Marc-Vergnes JP. Quantitative assessment of cerebral blood volume by single-photon emission computed tomography. Stroke 1991; 22:324-330.
38. Powers WJ, Grubb RL, Raichle ME. Clinical results of extracranial-intracranial bypass surgery in patients with hemodynamic cerebrovascular disease. J Neurosurg 1989; 70:61-70.
39. Levin JM, Kaufman MJ, Ross MH, et al. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state and hemodynamic pertubation (abstr). Proc Soc Magn Reson 1995; 127.
40. Levin JM, Kaufman MJ, Ross MH, et al. Sequential dynamic susceptibility contrast MR experiments in human brain: residual contrast agent effect, steady state and hemodynamic pertubation. Magn Reson Med 1995; 34:655-663.
41. Runge VM, Kirsch JE, Wells JW, Dunworth JN, Hilaire L, Woolfolk CE. Repeat cerebral blood volume assessment with first pass MR imaging. JMRI 1994; 4:457-461.
42. Bonte FJ, Devous MD, Reisch JS. The effect of acetazolamide on regional cerebral blood flow in normal human subjects as measured by SPECT. Invest Radiol 1988; 23:564-568.
43. Leinsinger G, Piepgras A, Einhäupl K, Schmiedek P, Kirsch KM. Normal values of cerebrovascular reserve capacity after stimulation with acetazolamide measured by xenon 133 single-photon emission CT. Am J Nucl Med 1994; 15:1327-1332.
44. 15O and positron emission tomography: theory, procedure and normal values. J Comput Assist Tomogr 1980; 4:727-736.
45. 2 and CBF by the oxygen-15 inhalation techniques: results in normal volunteers and cerebrovascular patients. Eur Neurol 1981; 20:285-290.
46. Pantano P, Baron JC, Lebrum-Grandie P. Regional cerebral blood flow and oxygen consumption in human aging. Stroke 1985; 15:635-641.
47. Greenberg JH, Alavi A, Reivich M, Kuhl D, Uzzell B. Local cerebral blood volume response to carbon dioxide in man. Circ Res 1978; 48:324-331.
48. Okudaira Y, Bandoh K, Arai H, Sato K. Evaluation of the acetazolamide test: vasoreactivity and cerebral blood volume. Stroke 1995; 26:1234-1239.
49. Powers WJ, Raichle ME. Positron emission tomography and its application to the study of cerebrovascular disease in man. Stroke 1985; 16:361-376.
50. Gibbs JM, Wise RJS, Leenders KL, Jones T. Evaluation of cerebral perfusion reserve in patients with carotid artery occlusion. Lancet 1984; 1:310-314.
51. Büll U, Reiche W, Kaiser HJ, et al. Cerebral blood flow to cerebral blood volume relationship as a correlate to cerebral perfusion reserve in stimulated cerebral blood flow. In: Schmiedek P, Einhäupl K, Kirsch CM, eds. Stimulated cerebral blood flow. Berlin, Germany: Springer Verlag, 1992; 111-120.
52. Toyama H, Takeshita G, Takeauchi A, et al. Cerebral hemodynamics in patients with chronic obstructive carotid disease by rCBF, rCBV, and rCBV/rCBF ratio using SPECT. J Nucl Med 1990; 31:55-60.